These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13987288)

  • 1. The intravenous use of uracil mustard (U-8344). A preliminary report.
    SCHUMACHER HR; O'CONNELL JP
    Cancer; 1963 Mar; 16():345-9. PubMed ID: 13987288
    [No Abstract]   [Full Text] [Related]  

  • 2. [EXPERIMENTAL STUDIES ON CARCINOMA AND ITS ARRESTED STATE. 9. PHARMACOLOGY OF URACIL MUSTARD, A CHEMOTHERAPEUTIC ANTINEOPLASTIC AGENT].
    CHANG M
    Nihon Yakurigaku Zasshi; 1964 Sep; 60():413-34. PubMed ID: 14271233
    [No Abstract]   [Full Text] [Related]  

  • 3. [EFFECT OF SOME ANTINEOPLASTIC AGENTS ON LIVER FUNCTION IN THE MOUSE].
    SYRKII AB; MIKHAILOVA AM
    Klin Lech Zlokach Novoobraz; 1963; 92():135-8. PubMed ID: 14182288
    [No Abstract]   [Full Text] [Related]  

  • 4. Sarcoma 180 inhibition by combinations of 6-thioguanine and uracil mustard.
    BOOTH BA; SARTORELLI AC
    Science; 1962 Oct; 138(3539):518-9. PubMed ID: 14013827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard.
    GOLD GL; SALVIN LG; SHNIDER BI
    Cancer Chemother Rep; 1962 Feb; 16():417-9. PubMed ID: 13899670
    [No Abstract]   [Full Text] [Related]  

  • 6. The antitumor activity of 5-bis-2'-chlorethyl)-aminouracil (uracil mustard).
    LANE M; KELLY MG
    Cancer Res; 1960 May; 20():511-7. PubMed ID: 14413839
    [No Abstract]   [Full Text] [Related]  

  • 7. CLINICAL EVALUATION OF URACIL MUSTARD.
    WILLIAMS HM
    Cancer Chemother Rep; 1963 Oct; 32():73-6. PubMed ID: 14088838
    [No Abstract]   [Full Text] [Related]  

  • 8. Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma.
    KENNEDY BJ; THEOLOGIDES A
    N Engl J Med; 1961 Apr; 264():790-3. PubMed ID: 13752496
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of uracil mustard in chronic lymphatic leukemia and malignant lymphoma.
    KENNEDY BJ; THEOLOGIDES A
    Cancer Chemother Rep; 1961 Apr; 11():77-80. PubMed ID: 13752495
    [No Abstract]   [Full Text] [Related]  

  • 10. URACIL MUSTARD: A POTENT INDUCER OF LUNG TUMORS IN MICE.
    ABELL CW; FALK HL; SHIMKIN MB; WEISBURGER EK; WEISBURGER JH; GUBAREFF N
    Science; 1965 Mar; 147(3664):1443-5. PubMed ID: 14268720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopan.
    WHITE FR
    Cancer Chemother Rep; 1961 Oct; 14():169-73. PubMed ID: 14006515
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic spectrum of uracil-mustard, a new oral antitumor drug. With special reference to the effects of small dosage in lymphomas, chronic leukemias, and ovarian carcinoma.
    SHANBROM E; MILLER S; HAAR H; OPFELL R
    JAMA; 1960 Nov; 174():1702-5. PubMed ID: 13750663
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopan and related compounds.
    LARIONOV L
    Cancer Chemother Rep; 1961 Jun; 12():205-6. PubMed ID: 13759106
    [No Abstract]   [Full Text] [Related]  

  • 14. ALTERATIONS IN CELLULAR METABOLISM ASSOCIATED WITH CELL DEATH INDUCED BY URACIL MUSTARD AND 6-THIOGUANINE.
    BOOTH BA; CREASEY WA; SARTORELLI AC
    Proc Natl Acad Sci U S A; 1964 Dec; 52(6):1396-402. PubMed ID: 14243513
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the biological activity of uracil mustard and Dopan.
    PETERING HG; BUSKIRK HH; MUSSER EA; EVANS JS
    Cancer Chemother Rep; 1963 Mar; 27():1-10. PubMed ID: 13942713
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of immediate results in the treatment of lymphogranulomatosis with dopan and degranol].
    RAEVSKII IG
    Vopr Onkol; 1962; 8(4)():3-11. PubMed ID: 14489811
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of combinations of uracil mustard (NSC-34462) and 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) [KTS; NSC-82116] against murine tumors.
    Petering HG; Buskirk HH; Crim JA
    Cancer Chemother Rep; 1966 Nov; 50(8):557-64. PubMed ID: 5978728
    [No Abstract]   [Full Text] [Related]  

  • 18. ANTITUMOR EFFECT OF OLIVOMYCIN COMBINED WITH VARIOUS SYNTHETIC CYTOTOXIC DRUGS.
    ROSSOLIMO OK; LEPESHKINA GN
    Fed Proc Transl Suppl; 1964; 23():484-6. PubMed ID: 14185884
    [No Abstract]   [Full Text] [Related]  

  • 19. THERAPEUTIC EFFECT OF ANTICANCER DRUGS ON SKIN CANCER.
    HIGUCHI K; UEMATSU K
    Kyushu J Med Sci; 1963 Oct; 14():203-9. PubMed ID: 14104458
    [No Abstract]   [Full Text] [Related]  

  • 20. Uracil mustard and 5-fluorouracil combination chemotherapy: a historic record.
    Kohorn EI
    Conn Med; 2013 Aug; 77(7):433-6. PubMed ID: 24195184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.